Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study

Saved in:

Bibliographic Details
Published in:	American journal of transplantation Vol. 14; no. 8; pp. 1817 - 1827
Main Authors:	KLINTMALM, G. B, FENG, S, AGARWAL, M, HARLER, M. B, GARCIA-VALDECASAS, J.-C, LAKE, J. R, VARGAS, H. E, WEKERLE, T, AGNES, S, BROWN, K. A, NASHAN, B, ROSTAING, L, MEADOWS-SHROPSHIRE, S
Format:	Journal Article
Language:	English
Published:	Hoboken, NJ Wiley 01-08-2014
Subjects:	Biological and medical sciences Fundamental and applied biological sciences. Psychology Fundamental immunology Medical sciences Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue, organ and graft immunology Digestive system Liver Transplantation Belatacept Homotransplantation De novo Immunomodulator Experience Immunosuppression Randomization Treatment Surgery Phase II trial Graft Immunosuppressive agent Fusion protein
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1600-6135 1600-6143
DOI:	10.1111/ajt.12810